Nurix Therapeutics Inc — 四半期キャッシュフロー (NASDAQ:NRIX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 669.34 M636.13 M591.55 M522.47 M688.13 M 負債合計 142.35 M155.24 M143.95 M150.22 M149.39 M 純資産合計 526.99 M480.89 M447.6 M372.25 M538.75 M 負債および純資産合計 669.34 M636.13 M591.55 M522.47 M688.13 M 有利子負債合計 ————— 純負債 —————

ニュース

Does Nurix Therapeutics (NRIX) Have the Potential to Rally 85.84% as Wall Street Analysts Expect?

Company News for Apr 9, 2026

Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Lags Revenue Estimates

Nurix Therapeutics (NRIX) Moves 6.9% Higher: Will This Strength Last?

Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates

Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates

Nurix Therapeutics amends equity distribution agreement for $413.65 million stock offering

キャシー・ウッドのARK、ロク株を売却、AlibabaとバイオテクノロジーETFを購入

Nurix（NRIX）の最高法務責任者Ring氏が125,792ドル相当の株式を売却

Ring, chief legal officer, sells Nurix (NRIX) shares for $125,792

Nurix Therapeutics Stock Sees RS Rating Jump To 82

Nurixのチーフ法務責任者リング・クリスティン氏、NRIXの株式を237,000ドル分売却